- Home
- TOMZ vs INAB Comparison
TOMZ vs INAB Comparison
Compare TOMZ & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- INAB
- Stock Information
- Founded
- TOMZ 1979
- INAB 2016
- Country
- TOMZ United States
- INAB United States
- Employees
- TOMZ N/A
- INAB N/A
- Industry
- TOMZ Diversified Commercial Services
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- INAB Health Care
- Exchange
- TOMZ Nasdaq
- INAB Nasdaq
- Market Cap
- TOMZ 20.2M
- INAB 18.8M
- IPO Year
- TOMZ N/A
- INAB 2021
- Fundamental
- Price
- TOMZ $0.94
- INAB $0.27
- Analyst Decision
- TOMZ Strong Buy
- INAB Strong Buy
- Analyst Count
- TOMZ 1
- INAB 3
- Target Price
- TOMZ $3.50
- INAB $5.57
- AVG Volume (30 Days)
- TOMZ 30.6K
- INAB 14.2M
- Earning Date
- TOMZ 03-31-2025
- INAB 03-13-2025
- Dividend Yield
- TOMZ N/A
- INAB N/A
- EPS Growth
- TOMZ N/A
- INAB N/A
- EPS
- TOMZ N/A
- INAB N/A
- Revenue
- TOMZ $8,197,404.00
- INAB N/A
- Revenue This Year
- TOMZ $40.32
- INAB N/A
- Revenue Next Year
- TOMZ $38.17
- INAB N/A
- P/E Ratio
- TOMZ N/A
- INAB N/A
- Revenue Growth
- TOMZ N/A
- INAB N/A
- 52 Week Low
- TOMZ $0.52
- INAB $0.22
- 52 Week High
- TOMZ $1.50
- INAB $1.74
- Technical
- Relative Strength Index (RSI)
- TOMZ 45.57
- INAB 47.53
- Support Level
- TOMZ $0.89
- INAB $0.25
- Resistance Level
- TOMZ $1.08
- INAB $0.30
- Average True Range (ATR)
- TOMZ 0.06
- INAB 0.04
- MACD
- TOMZ -0.01
- INAB 0.00
- Stochastic Oscillator
- TOMZ 26.32
- INAB 19.95
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales, service and licensing of its SteraMist brand of products, including SteraMist BIT, a low percentage (7.8%) hydrogen peroxide-based fog or mist that uses Binary Ionization Technology (BIT). Its product portfolio includes SteraMist Surface Unit; SteraMist Environment System; The SteraMist Total Disinfection Cart; SteraMist Select Surface Unit; Stainless Steel 90 Degree Applicator; iHP Plasma Decontamination Chamber; SteraMist Custom Engineered System (CES); and iHP Corporate Service Decontamination.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.